Renal Artery Stenosis Management
Initial Treatment
- The American Heart Association recommends medical therapy as the initial treatment for all patients with renal artery stenosis, regardless of etiology 1, 2
- The European Society of Cardiology suggests that optimal medical therapy should include calcium channel blockers, beta-blockers, and diuretics as the foundation of antihypertensive treatment 3, 4
Medical Management
- High-intensity statin therapy is recommended for lipid reduction and cardiovascular risk management in patients with renal artery stenosis 1, 4
- Antiplatelet therapy, such as low-dose aspirin, is recommended for cardiovascular protection in patients with renal artery stenosis 2, 4
- Smoking cessation and hemoglobin A1c reduction in diabetic patients are crucial for managing renal artery stenosis 1
Blood Pressure Targets
- The goal blood pressure for most patients with renal artery stenosis is <140/90 mmHg, which often requires at least 3 antihypertensive medications, including a diuretic 4, 6
Revascularization Indications
- Revascularization should be considered only after establishing optimal medical therapy in patients with bilateral stenosis >70% or stenosis in a solitary kidney with high-risk features and kidney viability 2, 3
- The European Heart Journal recommends revascularization for patients with refractory hypertension despite maximally tolerated doses of ≥3 antihypertensive medications 1, 2, 6
Kidney Viability Assessment
- The 2024 ESC guidelines mandate assessment of kidney viability before considering revascularization, using signs such as kidney size >8 cm, distinct cortex >0.5 cm, albumin-creatinine ratio <20 mg/mmol, and renal resistance index <0.8 2
- The European Heart Journal suggests that kidney size <7 cm, loss of corticomedullary differentiation, albumin-creatinine ratio >30 mg/mmol, and renal resistance index >0.8 are signs of non-viability 2
Special Considerations
- For fibromuscular dysplasia, revascularization with balloon angioplasty without stenting is the preferred treatment and has more favorable outcomes than atherosclerotic disease 2, 3